Figures computed from official regulatory filings — .
Enough buys on record, but none of them has a 63-day return yet — this happens when the shares stopped trading, or when the buys are too recent. Win rates will appear once returns mature.
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
RAPT Therapeutics, Inc.Listing unverified | Other | n/a (No price was disclosed in the filing) | SEC | ||
RAPT Therapeutics, Inc.Listing unverified | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
RAPT Therapeutics, Inc.Listing unverified | Other | n/a (No price was disclosed in the filing) | SEC | ||
RAPT Therapeutics, Inc.Listing unverified | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
NGM BIOPHARMACEUTICALS INCListing unverified | Buy | $21.7K | conv 25Cluster | SEC | |
NGM BIOPHARMACEUTICALS INCListing unverified | Buy | $180K | conv 29Cluster | SEC | |
NGM BIOPHARMACEUTICALS INCListing unverified | Buy | $373.6K | conv 52Cluster | SEC | |
NGM BIOPHARMACEUTICALS INCListing unverified | Buy | $14.7K | conv 34Cluster | SEC | |
NGM BIOPHARMACEUTICALS INCListing unverified | Buy | $430.9K | conv 34Cluster | SEC | |
NGM BIOPHARMACEUTICALS INCListing unverified | Buy | $413.7K | conv 34Cluster | SEC | |
NGM BIOPHARMACEUTICALS INCListing unverified | Buy | $14.1K | conv 34Cluster | SEC | |
NGM BIOPHARMACEUTICALS INCListing unverified | Buy | n/a (No price was disclosed in the filing) | conv 46ClusterFirst in 12mo | SEC | |
NGM BIOPHARMACEUTICALS INCListing unverified | Buy | n/a (No price was disclosed in the filing) | conv 46ClusterFirst in 12mo | SEC |